The Cancer Immunology Training Program began in 1977, and offers a comprehensive training program in cancer immunology for both pre-doctoral and post-doctoral fellows. The training includes formal courses in the following topics: Basic Immunology, Biochemistry, Molecular Biology, Clinical Immunology, Tumor Immunology, Tumor Biology, Cellular Immunology, Immunochemistry, and Transplantation. The research training stresses interaction between different laboratories participating in the training program so that both pre- and post-doctoral fellows will have a maximum exposure to all areas of cancer immunology. The overall goal of the Program is to produce a sophisticated and highly trained investigator who can understand the relationship between the clinical aspects of cancer and the basic immunologic models designed to understand the neoplastic process and host defense to neoplastic disease. The Program emphasizes concepts concerned with the molecular and genetic events leading to neoplasia, functional and phenotypic characteristics of neoplastic lymphoid cells, immune surveillance, and new modalities for therapy. In addition, there is a strong emphasis on basic concepts in immunology and molecular biology. The faculty represents a wide variety of discipline ranging from basic immunology to tumor virology, molecular biology and clinical-oncology. The Program integrates both basic and clinical immunology and trains the pre-doctoral students through didactic teaching, formal research training, informal seminars, Works-in-Progress seminars, lectures by visiting professors, and clinical rounds in Immunology. During the first two years of the Program, the trainee takes a core course covering basic principals of molecular and cellular biology followed by a series of advanced courses to provide him with a solid foundation. upon which his knowledge of immunology and cancer biology will develop. During the first year each student rotates through a minimum of three laboratories before selecting his mentor. The dissertation research takes 3-5 years to complete. The post-doctoral fellow receives support during which time he actively works on an aspect of Cancer Immunology under the auspices of one of the Immunology faculty members. The training program is highly interdisciplinary and takes advantage of from several departments (or divisions) on campus including Oncology and Hematology, Surgery, Pathology, Microbiology, Dermatology, Cell Biology, Biochemistry, Ophthalmology, Rheumatology, and Internal Medicine.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009082-24
Application #
2894338
Study Section
Cancer Research Manpower and Education Review Committee (CRME)
Program Officer
Gorelic, Lester S
Project Start
1980-07-01
Project End
2001-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
24
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Chiang, Eugene Y; Henson, Maile; Stroynowski, Iwona (2002) The nonclassical major histocompatibility complex molecule Qa-2 protects tumor cells from NK cell- and lymphokine-activated killer cell-mediated cytolysis. J Immunol 168:2200-11
Arora, Vivek K; Fredericksen, Brenda L; Garcia, J Victor (2002) Nef: agent of cell subversion. Microbes Infect 4:189-99
Ungchusri, T; Chiang, E Y; Brown, G et al. (2001) Widespread expression of the nonclassical class I Qa-2 antigens in hemopoietic and nonhemopoietic cells. Immunogenetics 53:455-67
Evans, J T; Cravens, P; Gatlin, J et al. (2001) Pre-clinical evaluation of an in vitro selection protocol for the enrichment of transduced CD34+ cell-derived human dendritic cells. Gene Ther 8:1427-35
Niederkorn, J Y; Chiang, E Y; Ungchusri, T et al. (1999) Expression of a nonclassical MHC class Ib molecule in the eye. Transplantation 68:1790-9
Thai, T H; Du, F; Tsan, J T et al. (1998) Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers. Hum Mol Genet 7:195-202
Racila, E; Euhus, D; Weiss, A J et al. (1998) Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci U S A 95:4589-94
Jin, Y; Xu, X L; Yang, M C et al. (1997) Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. Proc Natl Acad Sci U S A 94:12075-80
Bouwer, H G; Seaman, M S; Forman, J et al. (1997) MHC class Ib-restricted cells contribute to antilisterial immunity: evidence for Qa-1b as a key restricting element for Listeria-specific CTLs. J Immunol 159:2795-801
Kitchens, R L; Munford, R S (1995) Modulation of protein tyrosine phosphorylation in human cells by LPS and enzymatically deacylated LPS. Prog Clin Biol Res 392:353-63

Showing the most recent 10 out of 23 publications